CT findings before and after azithromycin treatment of chronic lung allograft dysfunction

R. Vos, P. de Jong, B. Vanaudenaerde, S. Verleden, D. Van Raemdonck, L. Dupont, W. De Wever, J. Verschakelen, G. Verleden (Leuven, Belgium; Utrecht, Netherlands)

Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Session: Improving outcomes after lung transplantation
Session type: Poster Discussion
Number: 3065

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Vos, P. de Jong, B. Vanaudenaerde, S. Verleden, D. Van Raemdonck, L. Dupont, W. De Wever, J. Verschakelen, G. Verleden (Leuven, Belgium; Utrecht, Netherlands). CT findings before and after azithromycin treatment of chronic lung allograft dysfunction. Eur Respir J 2011; 38: Suppl. 55, 3065

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between CT and spirometric changes in azithromycin treatment of chronic lung allograft dysfunction
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011

The acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function study
Source: Eur Respir J 2012; 40: 298-305
Year: 2012



New imaging techniques for chronic lung allograft dysfunction
Source: International Congress 2016 – New frontiers in lung transplantation
Year: 2016


Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation
Source: Annual Congress 2012 - Novel approaches to lung transplantation
Year: 2012

HRCT imaging of lung parenchyma in chronic heart failure (CHF) patients: correlation with pulmonary function tests
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008

Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 6 (4) 00261-2019; 10.1183/23120541.00261-2019
Year: 2020



The relationship between radiologic findings and lung function impairment in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
Source: Eur Respir J 2016; 48: 843-851
Year: 2016



Lung volumes predict survival in patients with chronic lung allograft dysfunction
Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016
Year: 2017



Hyperinflation correlates with poor exercise tolerance in recipients with advanced chronic lung allograft dysfunction
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012

The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002

The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 433s
Year: 2002

Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Safety of antifibrotic drugs in idiopathic pulmonary fibrosis patients awaiting lung transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 138s
Year: 2001

Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019
Year: 2020



KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016